Estados Unidos · Plataformas y datos · MarketBeat

Compass Pathways (NASDAQ:CMPS) Price Target Cut to $10.00 by Analysts at Wells Fargo & Company

Publicado por MarketBeat · Estados Unidos hace 1 h

Wells Fargo & Company dropped their price objective on Compass Pathways from $13.00 to $10.00 and set an "equal weight" rating for the company in a report on Wednesday.

Leer el artículo completo en MarketBeat Inicie sesión para guardar

MarketNews muestra el titular y el resumen publicados por el medio. El artículo completo se lee en el sitio del editor. (www.marketbeat.com)

Compass Pathways (NASDAQ:CMPS) Price Target Cut to $10.00 by Analysts at Wells Fargo & Company

También te puede interesar

Moderna says Ebola vaccine picked for Phase 2/3 trial in Africa

Why Palantir Technologies Stock Dropped Today

Medicare prescription drug costs will jump 50% in 2027. Doing nothing could cost you.

10-year Treasury yield is little changed as traders mull over Democrats' midterm victories

Jack Dorsey-led Block’s DOJ settlement overshadows Q3 profit

Sellas To Present SLS009 Data At American Society of Hematology – Initial Results Of Therapy In Newly Diagnosed AML Patients Expected In Q4

Compass Pathways (NASDAQ:CMPS) Price Target Cut to $10.00 by Analysts at Wells Fargo & Company

Compartir

También te puede interesar

Moderna says Ebola vaccine picked for Phase 2/3 trial in Africa

Why Palantir Technologies Stock Dropped Today

Medicare prescription drug costs will jump 50% in 2027. Doing nothing could cost you.

10-year Treasury yield is little changed as traders mull over Democrats' midterm victories

Jack Dorsey-led Block’s DOJ settlement overshadows Q3 profit

Sellas To Present SLS009 Data At American Society of Hematology – Initial Results Of Therapy In Newly Diagnosed AML Patients Expected In Q4